Atria Investments
CHRS icon

Atria Investments’s Coherus Oncology CHRS Stock Holding History

Atria Investments’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37K Sell
26,426
-10,965
-29% -$17.9K ﹤0.01% 2108
2026
Q1 		$63.2K Buy
+37,391
New +$66.4K ﹤0.01% 2021

Other funds holding CHRS

TGY2IT
Timothy G. Youngquist 2020 Irrevocable Trust Fort Myers, Florida $530M AUM 95.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Kohlberg Kravis Roberts & Co
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Atria Investments's CHRS Position: Q2 2026 in Review

Atria Investments reduced its Coherus Oncology (CHRS) stake by 29% in Q2 2026, selling an estimated $17.9K and leaving 26,426 shares worth $37K. The position accounts for ﹤0.01% of the portfolio, ranked #2108.

Atria Investments first reported a position in CHRS in Q1 2026 and has held it in 2 quarters since. The position peaked at $63.2K in Q1 2026. 146 funds tracked by Wall St. Rank hold CHRS as of Q2 2026.

  • Atria Investments held 26,426 shares of Coherus Oncology worth $37K as of Q2 2026.
  • Atria Investments sold 10,965 Coherus Oncology shares in Q2 2026, an estimated $17.9K.
  • Coherus Oncology made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2108 holding.
  • Atria Investments first reported a position in Coherus Oncology in Q1 2026 and has held it in 2 quarters since.
  • Atria Investments's Coherus Oncology position peaked at $63.2K in Q1 2026.
  • 146 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.